Fig. 5. mezzo, casanova, bon/mixer and ntl are immediate early
targets of Nodal signalling, while sox17 requires post MBT protein
synthesis. Embryos at the one- to four-cell stage were microinjected with 50
pg of TARAM-A* mRNA, treated continuously with 50 µg/ml of
cycloheximide, starting at the 64- to 128-cell stage and analysed at dome-30%
epiboly stage for the expression of sox17 (A-E), ntl (F-J),
mezzo (K-O) and casanova (P-T). (A,F,K,P) Untreated and
uninjected control embryos. (B,G,L,Q) Uninjected control embryos treated with
cycloheximide. (C,H,M,R) Control untreated embryos injected with
TARAM-A*. (D,E,I,J,N,O,S,T), Embryos injected with
TARAM-A* and treated with cycloheximide. Although treatment with
cycloheximide prevents induction of sox17, some ectopic mezzo,
ntl, bon/mixer and cas expression is clearly visible in absence
of protein synthesis.